Ujvira 160mg Injection: Effective Medication for Your Needs

Uses:

• Treatment of adults with human epidermal growth factor receptor 2 positive breast cancer that has spread or has not improved after treatment with other medications.
• Adjuvant therapy after surgery to kill any cancer cells left in the breast.

Therapeutic Effects:

• Trastuzumab binds selectively to the HER2 receptors on breast cancer cells' surface, blocks them from receiving growth signals, and stops the cancer cell's growth.
• DM1 becomes active once the drug enters the cancer cells and helps stop cancer cell growth.

Interaction with Other Drugs:

• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment.
• Certain medications may interact with Ujvira 160mg Injection and cause undesirable side effects.

Safety Advices:

• Pregnancy: discuss with your physician before taking this Ujvira 160mg Injection if you are pregnant or think you might be pregnant.
• Breast Feeding: avoid breastfeeding your baby while on the treatment with Ujvira 160mg Injection at least for at least seven months after the final dose.
• Lungs: talk to your doctor if you have any lung conditions before starting treatment with Ujvira 160mg Injection.
• Liver: you need to tell your physician if you have any liver disorders before starting Ujvira 160mg Injection as it requires dosage adjustment for severe liver impairment.
• Alcohol: consult your doctor to know if it is safe to consume alcohol while you are on treatment with Ujvira 160mg Injection.
• Driving: Ujvira 160mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.

Side Effects:

• Serious: heart problems, allergic reactions, kidney problems, breathing difficulties.
• Common: fever, visual disturbances, nose bleeds or runny nose, hair loss, dizziness, nail disorders, weight loss, loss of appetite, bruising, dry mouth, liver inflammation, muscle pain, asthma/lung disorders.

Word of Advice:

• Inform your doctor if you have a history of allergic reactions to Ujvira 160mg Injections to avoid life-threatening complications.
• If you have a history of lung disorder or breathing problems, inform your doctor before the treatment commencement.
• Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose.
• Monitor your heart parameters regularly during the treatment with Ujvira 160mg Injection as it may impact the functioning of the heart.
• Always maintain a healthy and balanced diet to support your overall health and well-being.

FAQs:

1. Is Ujvira 160mg Injection used as a monotherapy in treating breast cancer?

• Ujvira 160mg Injection is generally given along with the chemotherapy medication such as paclitaxel or docetaxel or platinum compounds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.

2. Does Ujvira 160mg Injection cause heart problems?

• Yes, Ujvira 160mg Injection can damage the heart muscles. Hence, to prevent the worsening of symptoms, it is advised to do a heart check up every 3 months and continue till 2-5 years after the treatment completion.

3. Can Trastuzumab emtansine cause hair loss?

• Hair loss is not a common side effect of Trastuzumab emtansine treatment, but some patients may experience thinning or loss of hair due to chemotherapy or other cancer treatments.

4. How long does Trastuzumab emtansine treatment last?

• The length of Trastuzumab emtansine treatment will depend on the patient's case, including the stage and type of breast cancer and their response to the medication. In some cases, the treatment may continue for several months or years.

Fact Box:

• Molecule name: Trastuzumab.
• Therapeutic class: Anti-cancer.
• Pharmacological class: HER2 inhibitor.
• Indications: Breast cancer.

Tags: Ujvira, injection, medical, drug, 160mg, pharmaceutical, medication